Antibodies to FeRn and uses thereof
US9260520B2 · kind B2 · utility
16Cited by
32References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 30, 2014 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Jan 30, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.